July, 2014 11:00am – 12:00pm (EST) Presenter: Patricia W. Mueller, Ph.D. Researchers, clinical laboratories, and companies are developing next-generation sequencing (NGS) applications that include newborn screening (NBS). Accurate NGS sequence depends on certain key processes. It has recently been determined that in the human genome approximately 17% of the known functional genes
NIH Special SCIENCE SERIES (#5): Cancer Vaccine – Unique Tumor-Associated Antigen This webinar has already taken place. However, you can watch a recording of it by clicking on the screen shot just below. Originally aired on February 18th, 2016 FREE take-away: To know more about this technology, please download the PDF here. One Million Solutions in Health™
NIH Special SCIENCE SERIES: Groundbreaking Biomarker to be Used as Companion Diagnostic to Aid in Clinical Decision-Making for Cancer Treatments . This webinar has already taken place. However, you can watch a recording of it by clicking on the screen shot just below. Originally aired on November 19th, 2015 FREE take-away: To know more about this technology,
NIH SPECIAL SCIENCE SERIES: Novel Mouse Strain for Therapeutic Compound Screening for Human Age-related Macular Degeneration (AMD) This webinar has already taken place. However, you can watch a recording of it by clicking on the screen shot just below. Originally aired on October 21st, 2015 One Million Solutions in Health™ has established a one-of-a-kind, new
NIH SPECIAL Science SERIES: Groundbreaking Molecules that will Revolutionize Autophagy Induction for Treating Huntington’s Disease, and potentially Alzheimer’s and Parkinson’s Diseases . This webinar has already taken place. However, you can watch a recording of it by clicking on the screen shot just below. Originally aired on October 16th, 2015 FREE take-away: To know more about this
NIH Licensing Opportunity: A Novel Personalized Cell Therapy for Age-related Macular Degeneration LIVE EVENT ONLY. One Million Solutions in Health™ has established a one-of-a-kind, new partnership with the United States’ National Institutes of Health Office of Technology Transfer (NIH-OTT) and the National Cancer Institute Technology Transfer Center (NCI-TTC) to increase awareness and understanding of NIH